微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.11% | 414.63% | 109.12% | 48/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | -23.14% | 42.55% | -1528.4% | 132/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 1.62% | 113.79% | 852.94% | 97/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | 0.17% | 103.73% | -58.54% | 105/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 0.41% | 126.97% | 101.02% | 101/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | -40.28% | -77.92% | -242.81% | 140/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | -11.75% | -56.88% | -157.68% | 135/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | -4.56% | 3.39% | -200% | 131/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | -1.52% | 47.4% | 93.29% | 124/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | -22.64% | 40.96% | -202.27% | 134/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | -7.49% | 38% | -58.69% | 128/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | -4.72% | -7.03% | -63.32% | 124/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | -2.89% | -256.22% | 92.46% | 130/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | -38.35% | -560.38% | -217.47% | 141/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | -12.08% | -217.62% | -173.92% | 130/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | -4.41% | -164.66% | -338.38% | 130/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 1.85% | -51.57% | -77.79% | 62/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 8.33% | 12.26% | -18.89% | 52/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 10.27% | 15.26% | 50.59% | 30/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 6.82% | 28.44% | 78.53% | 32/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 3.82% | 29.93% | -48.52% | 25/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 7.42% | -56.38% | -16.72% | 72/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 8.91% | 78.56% | 67.8% | 40/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 5.31% | 13.22% | 80.61% | 51/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 2.94% | -28.64% | -82.72% | 34/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 17.01% | 31.25% | 240.88% | 27/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 4.99% | -53.49% | 6.4% | 67/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 4.69% | -33.29% | 13.83% | 51/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 4.12% | 54.89% | -68.21% | 17/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 12.96% | -15.95% | 20.78% | 37/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 10.73% | -17.9% | 52.63% | 21/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 7.03% | -18.54% | 164.29% | 24/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 2.66% | -23.34% | -82.75% | 37/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 15.42% | -0.19% | 17.98% | 22/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 13.07% | -9.42% | 51.45% | 18/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 8.63% | -15.48% | 148.7% | 20/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 3.47% | -17.97% | -77.54% | 18/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 15.45% | -41.21% | 7.07% | 33/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 14.43% | 2% | 41.33% | 13/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 10.21% | 2% | 141.37% | 13/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 4.23% | 2% | -83.9% | 16/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |